What is the appropriate intramuscular dose of chlorpromazine (Thorazine) for acute agitation?

IM Chlorpromazine Dosing for Acute Agitation

For acute agitation in adults, administer chlorpromazine 25 mg IM initially, with repeat dosing of 25-50 mg in 1 hour if needed, up to 400 mg every 4-6 hours in severe cases, though chlorpromazine is NOT a first-line agent and should be reserved for specific situations where preferred alternatives are unavailable or contraindicated. 1

Critical Context: Chlorpromazine is NOT First-Line

Before discussing dosing, understand that chlorpromazine has largely fallen out of favor for acute agitation management:

• Current guidelines do NOT recommend chlorpromazine as first-line therapy for undifferentiated agitation 2
• Preferred agents include:
  • Haloperidol 5 mg IM (best evidence base among conventional antipsychotics)
  • Droperidol 5 mg IM (faster sedation, though has FDA black box warning)
  • Lorazepam 2-4 mg IM
  • Olanzapine 10 mg IM
  • Ziprasidone 10-20 mg IM

FDA-Approved IM Dosing (When Used)

Adults - General Agitation

Initial dose: 25 mg IM (1 mL) 1

Repeat dosing: If necessary, give 25-50 mg in 1 hour 1

Severe cases: Increase subsequent doses gradually over several days up to 400 mg every 4-6 hours in exceptionally severe cases until patient controlled 1

Typical response time: Most patients become quiet and cooperative within 24-48 hours, at which point switch to oral dosing 1

Specific Clinical Scenarios

Prompt control of severe symptoms:

• 25 mg IM initially
• Repeat in 1 hour if necessary
• Switch to oral 25-50 mg TID thereafter 1

Presurgical apprehension:

• 12.5-25 mg IM, 1-2 hours before operation 1

Pediatric Dosing (6 months - 12 years)

Severe behavioral problems:

• 0.25 mg/lb (0.55 mg/kg) IM every 6-8 hours as needed 1

Maximum daily IM doses:

• Up to 5 years (or 50 lbs): Not over 40 mg/day
• 5-12 years (or 50-100 lbs): Not over 75 mg/day except in unmanageable cases 1

Critical Safety Considerations

Administration Technique

• Inject slowly, deep into upper outer quadrant of buttock 1
• Keep patient lying down for at least 30 minutes after injection due to hypotensive effects 1
• AVOID injecting undiluted chlorpromazine into vein - IV route only for specific indications (severe hiccups, surgery, tetanus) 1
• If irritation occurs, dilute with saline or 2% procaine 1
• Never give subcutaneously 1

Hypotension Risk

Chlorpromazine carries significant hypotension risk, particularly with IM/IV routes:

• Recent geriatric data shows IM/IV antipsychotics have 7-10 times higher adverse event rates compared to oral formulations (OR 7.63 for IM, OR 10.17 for IV) 3
• Reserve parenteral administration for bedfast patients only or acute ambulatory cases with appropriate monitoring 1
• One ICU study found median MAP decreased from 88 to 83 mmHg (statistically significant but clinically modest when infused slowly at 1 mg/min IV) 4

Age-Specific Warnings

Elderly patients:

• More susceptible to hypotension and neuromuscular reactions 1
• 2025 geriatric guidelines show 16.8% adverse event rate with antipsychotics for agitation in older adults 3
• Oral quetiapine has more favorable safety profile than parenteral chlorpromazine in this population 3
• Increase dosage more gradually; observe closely 1

Drug Interactions

• 38% of chlorpromazine administrations resulted in drug-drug interactions in one pediatric study 5
• Avoid in anticholinergic or sympathomimetic toxicity (can worsen agitation due to anticholinergic effects) 2

Extrapyramidal Symptoms

• Chlorpromazine causes EPS and movement disorders 6, 5
• Have diphenhydramine or benztropine available for dystonic reactions
• Consider this when combination therapy with haloperidol + lorazepam + diphenhydramine is commonly preferred 7

Clinical Algorithm for Agitation Management

Step 1: Attempt verbal de-escalation and non-pharmacologic interventions first 3, 2

Step 2: If cooperative, offer oral medications (preferred over IM due to safety) 3

• Oral quetiapine or risperidone + lorazepam 3, 2

Step 3: If parenteral needed, use first-line agents:

• Haloperidol 5 mg IM (best evidence) 2
• Droperidol 5 mg IM (faster, but monitor QTc) 2
• Olanzapine 10 mg IM (lower EPS risk) 2
• Lorazepam 2-4 mg IM 2

Step 4: Chlorpromazine 25 mg IM only if:

• First-line agents unavailable
• Patient has failed or has contraindications to preferred agents
• Specific clinical scenario warrants (e.g., intractable hiccups, tetanus adjunct)

Step 5: Monitor blood pressure closely for 30+ minutes post-injection 1

Common Pitfalls

• Using chlorpromazine as first-line when better-tolerated options exist
• Inadequate blood pressure monitoring post-injection
• Combining with benzodiazepines in elderly (significantly increases adverse events) 3
• IV bolus administration instead of slow infusion (increases hypotension risk)
• Standing patient up too quickly after IM injection
• Ignoring underlying medical causes of agitation before medicating 2

Efficacy Data

Limited recent data exists for chlorpromazine specifically:

• One pediatric ED study showed 50% response rate at 1 hour with mean dose 29 mg (0.53 mg/kg) 6
• 14% of administrations were ineffective for managing agitation in another pediatric study 5
• 35% experienced side effects possibly related to chlorpromazine 5

These modest efficacy rates and high side effect profiles further support using alternative agents when possible.